Q2 2016 Holdings
Filed 2016-08-15 | 23 holdings | $123.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris therapeutics(ACRS) | Common | 00461U105 | $77.4M | 4,191,397 | 62.7% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $23.4M | 1,766,832 | 19.0% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $22.5M | 5,573,319 | 18.2% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $97.3K | 6,495,416 | 0.1% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $31.7K | 1,599,591 | 0.0% |
| Nabriva Therapeutics AG | ADR | 62957M104 | $23.6K | 3,151,700 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $15.4K | 2,019,955 | 0.0% |
| Advanced Accelerator Applications S.A. | Common | 00790T100 | $13.8K | 455,798 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $10.9K | 1,728,000 | 0.0% |
| Capnia, Inc. | Common | 14066L105 | $8.7K | 7,456,984 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common | 00900T107 | $8.3K | 763,009 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $7.9K | 990,449 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $7.1K | 527,842 | 0.0% |
| Dynavax Technologies Corporation(DVAX) | Common | 268158201 | $5.2K | 359,828 | 0.0% |
| ProNAi Therapeutics, Inc. | Common | 74346L101 | $4.9K | 2,438,270 | 0.0% |
| Carbylan Therapeutics | Common | 141384107 | $2.8K | 4,204,562 | 0.0% |
| Minerva Neurosciences, Inc.(NERVGBP) | Common | 603380106 | $2.0K | 200,000 | 0.0% |
| MEI Pharma, Inc. | Common | 55279B202 | $1.5K | 1,101,129 | 0.0% |
| ReVance Therapeutics, Inc.(RVNCEUR) | Common | 761330109 | $1.1K | 77,373 | 0.0% |
| Ocera Therapeutics, Inc. | Common | 67552A108 | $291 | 153,331 | 0.0% |
| Capnia, Inc. | Warrant | 14066L113 | $245 | 943,858 | 0.0% |
| Zosano Pharma Corp | Common | 98979H103 | $125 | 98,515 | 0.0% |
| Palatin Technologies, Inc. | Common | 696077403 | $103 | 234,909 | 0.0% |